Abstract:Objective To investigate the expression of survivin,vascular endothelial growth factor(VEGF),and active caspase-3 in different phases of hemangiomas and analyze their relationship.Methods The samples of 15 normal controls and 45 hemangioma patients(30 proliferating and 15 involuting) were evaluated by immunohistochemistry to determine the expression of survivin,VEGF,and active caspase-3.The data were analyzed by Kuskal-Wallis H test,Mann-Whittney U test,and Spearman rank correlation.The values were considered significant at P0.05.Results(1) Survivin mainly localized in nucleus of the endothelial cell.Its positive rates were 80%(24/30) in proliferating hemangioma,60%(9/15) in involuting hemangioma,and 0(0/15),in normal tissue.The difference between proliferating and involuting hemangioma was statistically significant(P0.05),and their differences between the hemangioma groups and normal control group were also significant(P0.01).(2) VEGF mainly expressed in cytoplasm and membrane of the endothelial cell.Its positive rate was 90%(27/30) in proliferative hemangiomas,46.7%(7/15) in involuting hemangiomas,and 0(0/15) in normal tissues.The differences between the groups were statistically significant(P0.01).(3) Active caspase-3 mainly located in nucleus of the endothelial cell.Its positive rates were 60%(18/30) in proliferative phase,86.7%(13/15) in involuting phase,and 0(0/15) in normal tissue.The difference between proliferating and involuting hemangiomas was statistically significant(P0.05),and the differences between the hemangioma groups and normal control group were also statistically significant(P0.01).(4) VEGF in hemangioma showed positive correlation with survivin(r=0.54,P0.01),while active caspase-3 showed negative correlation with survivin(r=-0.51,P0.01).Conclusion Inhibition of caspase-3 by VEGF/survivin may play a key role in the conversion from proliferating hemangioma to involuting hemangioma.Molecular intervention in the inhibitory path may provide a new strategy for the management of hemangiomas and angiogenesis-dependent diseases.

Expression and Significance of Apoptosis-Related Factors of Mitochondrial Pathway in Different Phases of Infantile Hemangioma

[Expression of bcl-2 and survivin gene products in different stages of vessel differentiation in hemangiomas].

Expression and significance of hypoxia inducible factor-1α in different phases of hemangioma and vascular malformation in infants and children

The Study on Effect of Apoptosis-related Gene C-myc, Bcl-2 and P53 in Infancy Hemangiomas

Apoptosis Accompanying Involution of Infantile Hemangioma

The Expressions of Survivin and Bax in Hemangioma

Expression of Hypoxia Inducible Factor-1Α, 3α in Hemangioma

Research on Expression and Correlation of Survivin,Vascular Endothelial Growth Factor,and Active Caspase-3 in Different Phases of Hemangiomas

[Expression and Correlation of Mast Cell, Clusterin/apoJ and Transforming Growth Factor-Beta in the Different Stages of Human Dermal Hemangioma].

Expressions of Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Hemangioma

Proteomic analysis of mitochondria from infantile hemangioma endothelial cells treated with sodium morrhuate and its liposomal formulation.

The analysis of cell cycle and apoptosis with flow cytometry in hemangioma of children and its significance

Signaling pathways in the development of infantile hemangioma

Role Of Endothelial-Mesenchymal Transition In The Tumorigenesis Of Infantile Hemangioma

[Expression of Cellular Adhesion Molecules and HLA-DR Antigen on Vascular Endothelial Cells in Hemangiomas.].

[The Relationship Between the Expression of HIF-1alpha and the Angiogenesis in Infancy Hemangioma].

[Indentification of Differentially Expressed Genes in Proliferating and Involuting Hemangiomas by Cdan Microarray Analysis of Gene-Expression Profiles].

The Expression and Significance of Telomerase Reverse Transcriptase(TERT) in Infantile Hemangiomas

Biology of Infantile Hemangioma

Investigative Progress of Pathogenesis of Hemangioma

Expression of P57~(kip2) Protein in Human Dermal Hemangiomas and Its Significance